:: DelSiTech Ltd. ::

28.10.2005	DelSiTech Ltd receives Venture funding

30.06.2005	DelSiTech has signed its third international technology testing contract

29.11.2004	Mr Gunnar Bjorksten joins DelSiTech as Vice President of Business Development

26.10.2004	Second financing round completed

20.06.2003	Kai Lähdesmäki, Vice president of BioTie Therapies, is elected Chairman of the Board

18.06.2003	DelSiTech receives venture funding from Innofinance Oy and Traumatri Oy

15.06.2003	Harry Jalonen was elected CEO of DelSiTech Ltd

31.12.2002	The Silica-gel based patent portfolio consisting of 7 patent families was sold by Bioxid Ltd Oy to DelSiTech Ltd.

DelSiTech Ltd, Itäinen Pitkäkatu 4 B, 20520 Turku, Finland, Tel. +358 2 4788 640, Fax. +358 2 4788 120, Email: info